Dentalcorp sale suggests WELL Health is undervalued, Stifel says
Stifel analyst Justin Keywood maintained his “Buy” rating and C$9.00 target price for WELL Health Technologies (WELL Health Stock Quote, Chart, News, Analysts, Financials TSX:WELL) in a Sept. 29th note, arguing that recent Canadian healthcare take-outs...
2 days ago